Abstract
New product development is a strenuous and long process for companies. When the COVID-19 disease turned into a global pandemic, governments announced the need for various medical products that were scarce and at the same time imposed lockdowns and trade restrictions. During this period, rapid new product development of medical products was attempted by many companies worldwide using their existing supply chains. Data of 240 companies from non-medical product-segment background launching new medical products were collected and analyzed. Two case studies of Indian companies responding to shortages of ventilators and PPE are presented. A critical reflection of a new way of new product development and cooperation across firms is discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
